AtriCure Insider Sells 5,000 Shares

Vinayak Doraiswamy, an insider at the medical device company, reduces his stake by 4.91%

Mar. 16, 2026 at 2:38pm

Got story updates? Submit your updates here. ›

AtriCure, Inc. (NASDAQ:ATRC) insider Vinayak Doraiswamy sold 5,000 shares of the company's stock on March 12, 2026. The shares were sold at an average price of $29.83, for a total transaction value of $149,150. Following the sale, Doraiswamy now directly owns 96,875 shares in the company, valued at approximately $2,889,781.25.

Why it matters

Insider transactions, such as this sale by Vinayak Doraiswamy, can provide insights into management's views on the company's prospects. While a single transaction does not necessarily indicate a broader trend, it is still noteworthy when an insider reduces their stake, as it may signal a change in their outlook or a need for personal liquidity.

The details

Doraiswamy's sale represents a 4.91% decrease in his position in AtriCure. The company, which develops medical devices for the treatment of atrial fibrillation, has seen its stock price fluctuate in recent months, trading between $28.29 and $43.18 over the past 52 weeks.

  • The transaction occurred on Thursday, March 12, 2026.

The players

Vinayak Doraiswamy

An insider at AtriCure, Inc. who sold 5,000 shares of the company's stock.

AtriCure, Inc.

A medical device company that develops products for the treatment of atrial fibrillation.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by Vinayak Doraiswamy, while not necessarily indicative of broader trends, serves as a reminder for investors to closely monitor insider transactions as they can provide valuable insights into a company's prospects.